The study on the antitumor effect of medication for underlying diseases of the patients with unresectable pancreatic carcinoma who undergo standard chemotherapy.

The study on the antitumor effect of medication for underlying diseases of the patients with unresectable pancreatic carcinoma who undergo standard chemotherapy. - The study on the antitumor effect of concomitant drug with chemotherapeutic agent for the patients with unresectable pancreatic carcinoma.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000022938

Enrollment

Registered

2016-06-29

Start date

2016-06-29

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic carcinoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients with stage 4b pancreatic carcinoma

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Progression free survival	—

Secondary

Measure	Time frame
Response rate Disease control rate Overall survival	—

Countries

Japan

Contacts

Public ContactAkira Mitoro

Nara Medical University Department of Gastroenterology, Endocrinology and Metabolism

mitoroak@naramed-u.ac.jp0744-22-3051

Outcome results